Cargando…

Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias

Collapsin response mediator protein-2 (CRMP2) regulates axonal growth cone extension, and increased CRMP2 phosphorylation may lead to axonal degeneration. Axonal and synaptic pathology is an important feature of Lewy body dementias (LBD), but the state of CRMP2 phosphorylation (pCRMP2) as well as it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Huayang, Lim, Yun-An, Chong, Joyce R., Lee, Jasinda H., Aarsland, Dag, Ballard, Clive G., Francis, Paul T., Chen, Christopher P., Lai, Mitchell K. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016931/ https://www.ncbi.nlm.nih.gov/pubmed/27609071 http://dx.doi.org/10.1186/s13041-016-0264-9

Ejemplares similares

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
por: Chai, Yuek Ling, et al.
Publicado: (2023)

Decreased DHA‐containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ(42), phosphorylated α‐synuclein, and synaptopathology
por: Chong, Joyce R., et al.
Publicado: (2023)

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
por: Gibson, Lucy L., et al.
Publicado: (2023)

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
por: Howlett, David R., et al.
Publicado: (2014)

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
por: Stubendorff, Kajsa, et al.
Publicado: (2014)

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications
por: Mueller, Christoph, et al.
Publicado: (2017)

Structural synaptic signatures of Alzheimer's disease and dementia with Lewy bodies in the male brain
por: Glebov, Oleg O., et al.
Publicado: (2022)

Amyloid-beta-dependent phosphorylation of collapsin response mediator protein-2 dissociates kinesin in Alzheimer's disease
por: Mokhtar, Sara H., et al.
Publicado: (2018)

Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022
por: Abdelnour, Carla, et al.
Publicado: (2023)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Isoform‐specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias
por: Low, Clara Y. B., et al.
Publicado: (2021)

Mental health of people living with dementia in care homes during COVID-19 pandemic
por: Velayudhan, Latha, et al.
Publicado: (2020)

Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study
por: Rongve, A, et al.
Publicado: (2016)

Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Bereczki, Erika, et al.
Publicado: (2017)

Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia
por: Vallortigara, Julie, et al.
Publicado: (2014)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
por: Mulugeta, Ezra, et al.
Publicado: (2011)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Psychiatric and neuropsychiatric syndromes and COVID-19
por: Velayudhan, Latha, et al.
Publicado: (2020)

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
por: Abdelnour, Carla, et al.
Publicado: (2020)

Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia
por: Alghamdi, Amani, et al.
Publicado: (2017)

Clinical and Neuropsychological Differences between Mild Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Petrova, Mariya, et al.
Publicado: (2015)

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
por: Husebo, Bettina S, et al.
Publicado: (2011)

Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models
por: Ikezu, Seiko, et al.
Publicado: (2020)

Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes
por: Mueller, Christoph, et al.
Publicado: (2020)

An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
por: Datta, Arnab, et al.
Publicado: (2017)

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
por: Berge, Guro, et al.
Publicado: (2014)

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson’s disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2013)

A Longitudinal Study of Neurocognition in Dementia with Lewy Bodies Compared to Alzheimer’s Disease
por: Breitve, Monica H., et al.
Publicado: (2018)

Neuropilin-1 Mediates Collapsin-1/Semaphorin III Inhibition of Endothelial Cell Motility: Functional Competition of Collapsin-1 and Vascular Endothelial Growth Factor-165
por: Miao, Hua-Quan, et al.
Publicado: (1999)

Research criteria for the diagnosis of prodromal dementia with Lewy bodies
por: McKeith, Ian G., et al.
Publicado: (2020)

Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disorders
por: Crews, Leslie, et al.
Publicado: (2011)

5.14 The Biophysics of Membrane Fusion
por: Collins, R.N., et al.
Publicado: (2012)

A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
por: Breitve, Monica H, et al.
Publicado: (2014)

A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer’s disease
por: Breitve, Monica H., et al.
Publicado: (2016)

Apathy is associated with faster global cognitive decline and early nursing home admission in dementia with Lewy bodies
por: Breitve, Monica H., et al.
Publicado: (2018)

Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
por: Swirski, Marta, et al.
Publicado: (2014)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

Pathologic Thr(175) tau phosphorylation in CTE and CTE with ALS
por: Moszczynski, Alexander J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1bqnu14li5ld1jakahhr9bphvq